XML 59 R87.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SEGMENT INFORMATION (Summary of Reportable Segments) (Details)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2019
USD ($)
Sep. 30, 2019
USD ($)
Jun. 30, 2019
USD ($)
Mar. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Sep. 30, 2018
USD ($)
Jun. 30, 2018
USD ($)
Mar. 31, 2018
USD ($)
Dec. 31, 2019
USD ($)
segment
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Financial information regarding the Company's reportable segments                      
Number of reportable segments | segment                 3    
Net sales $ 671,333 $ 701,278 $ 742,661 $ 744,460 $ 685,028 $ 665,775 $ 710,608 $ 703,350 $ 2,859,732 $ 2,764,761 $ 2,469,283
Acquisition related costs                 3,927 23,770  
Total Restructuring Initiatives                 20,472 63,829 2,208
Gain on insurance recovery                     10,648
Depreciation and amortization                 194,552 171,747 153,094
Interest expense                 (35,489) (32,626) (40,597)
Interest income                 4,174 7,056 5,470
Income before Income Taxes                 342,069 266,020 294,825
Capital Expenditures                 242,276 211,252 156,624
Total Assets 3,562,119       3,377,735       3,562,119 3,377,735 3,137,823
Business Transformation                      
Financial information regarding the Company's reportable segments                      
Total Restructuring Initiatives                 20,472 63,829 2,208
Capital Expenditures                 38,000    
Business Transformation | Employee severance                      
Financial information regarding the Company's reportable segments                      
Total Restructuring Initiatives                 8,104    
Beauty + Home                      
Financial information regarding the Company's reportable segments                      
Net sales                 1,352,714 1,426,382 1,313,786
Adjusted EBITDA                 181,150 185,926 173,227
Total Restructuring Initiatives                 17,682 52,244 529
Depreciation and amortization                 82,778 83,546 79,422
Capital Expenditures                 96,040 101,371 76,425
Total Assets 1,378,292       1,373,816       1,378,292 1,373,816 1,358,283
Pharma                      
Financial information regarding the Company's reportable segments                      
Net sales                 1,091,051 954,652 805,880
Adjusted EBITDA                 387,483 343,706 275,933
Total Restructuring Initiatives                 632 3,589  
Depreciation and amortization                 65,590 51,495 41,143
Capital Expenditures                 89,702 54,433 33,005
Total Assets 1,422,815       1,324,696       1,422,815 1,324,696 881,443
Food + Beverage                      
Financial information regarding the Company's reportable segments                      
Net sales                 415,967 383,727 349,617
Adjusted EBITDA                 68,108 57,589 62,903
Total Restructuring Initiatives                 391 4,185 1,679
Depreciation and amortization                 35,728 27,467 24,720
Capital Expenditures                 45,130 41,236 38,730
Total Assets 534,527       501,700       534,527 501,700 296,271
Corporate & Other                      
Financial information regarding the Company's reportable segments                      
Adjusted EBITDA                 (44,406) (36,285) (37,457)
Total Restructuring Initiatives                 1,767 3,811  
Depreciation and amortization                 10,456 9,239 7,809
Capital Expenditures                 13,933 25,739 18,924
Transfer of Corporate Technology Expenditures                 (2,529) (11,527) (10,460)
Total Assets $ 226,485       $ 177,523       226,485 177,523 601,826
Operating segment                      
Financial information regarding the Company's reportable segments                      
Net sales                 2,894,507 2,787,989 2,491,444
Operating segment | Beauty + Home                      
Financial information regarding the Company's reportable segments                      
Net sales                 1,376,027 1,446,231 1,333,048
Operating segment | Pharma                      
Financial information regarding the Company's reportable segments                      
Net sales                 1,100,463 955,069 805,913
Operating segment | Food + Beverage                      
Financial information regarding the Company's reportable segments                      
Net sales                 418,017 386,689 352,483
Intersegment                      
Financial information regarding the Company's reportable segments                      
Net sales                 (34,775) (23,228) (22,161)
Intersegment | Beauty + Home                      
Financial information regarding the Company's reportable segments                      
Net sales                 (23,313) (19,849) (19,262)
Intersegment | Pharma                      
Financial information regarding the Company's reportable segments                      
Net sales                 (9,412) (417) (33)
Intersegment | Food + Beverage                      
Financial information regarding the Company's reportable segments                      
Net sales                 $ (2,050) $ (2,962) $ (2,866)